FMCSA Receives Exemption Applications for Drivers with Epilepsy

FMCSA has announced that it has received four exemption applications from drivers who have epilepsy or a similar condition that can cause loss of consciousness.

What FMCSA Is Doing

The agency is reviewing the requests and has opened a comment period that ends on October 8, 2026.

Who Is Affected

The exemption would allow drivers who have had one or more seizures and are on anti‑seizure medication to operate commercial motor vehicles in interstate commerce.

What Carriers Should Do

Carriers should check if any of their drivers have a medical condition that could qualify for an exemption. They should review the FMCSA rules that prohibit drivers with epilepsy from operating CMVs. If a driver is applying for an exemption, carriers should keep records of the application and any medical documentation.

Carriers should also submit comments on the docket if they have concerns or support for the exemption. Comments are due by October 8, 2026. They can submit online, by mail, or by fax.

What Is Still Unclear

It is not yet clear what criteria FMCSA will use to decide whether to grant an exemption. The notice does not state how many seizures or what level of medication will be acceptable. Carriers should confirm how the rule applies to their drivers with the agency.

Interpretation

If an exemption is granted, the driver would be able to operate a CMV in interstate commerce. This would be a change from the current prohibition. Carriers should plan for potential changes in driver eligibility.

Next Steps

Until FMCSA issues a final decision, carriers should monitor the docket and keep up to date with any guidance. They should also maintain compliance with existing medical standards for CMV drivers.